Trial Information
Breast Cancer Siblings Database
OBJECTIVES:
- Collect blood samples and medical and background information from patients with
invasive breast cancer and their affected or unaffected siblings.
OUTLINE: Patients and their siblings undergo blood collection. They also complete medical
and background questionnaires.
Patients and their siblings are followed annually for 5 years.
PROJECTED ACCRUAL: A total of 1,000 patients and siblings will be accrued for this study.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Meets 1 of the following criteria:
- Pathologically confirmed invasive breast cancer (patient)
- No ductal carcinoma in situ
- Affected OR unaffected sibling
- Affected sibling must have had (or currently has) breast cancer only
- Unaffected sibling must be female
- No deceased siblings
- Must be a full-blood related sibling
- Patients receiving treatment on clinical trial ECOG-E1Y97 or ECOG-E3Y92 are not
eligible
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
Collection of blood samples and medical and background information
Principal Investigator
Richard A. Shapiro, MD
Investigator Role:
Study Chair
Investigator Affiliation:
GenBasix Incorporated
Authority:
Unspecified
Study ID:
CDR0000529353
NCT ID:
NCT00445562
Start Date:
January 2001
Completion Date:
Related Keywords:
- Breast Cancer
- male breast cancer
- recurrent breast cancer
- stage IA breast cancer
- stage IB breast cancer
- stage II breast cancer
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- Breast Neoplasms
Name | Location |
GenBasix Incorporated |
Duarte, California 91010 |